Scientists find method to probe genes of the most common bacterial STI

April 11, 2011

In a new study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, scientists describe successfully mutating specific genes of Chlamydia bacteria, which cause the most common sexually transmitted infection in the United States as well as a type of blindness common in developing nations. The procedure they used will help advance scientists' understanding of how these bacteria cause human disease and expedite the development of new strategies to prevent and control these infections.

The advance could end decades of frustration for scientists who until now have been unable to manipulate Chlamydia genes in the laboratory, inhibiting research progress in the field.

Traditionally, gene manipulation involves directly introducing foreign DNA into . But Chlamydia bacteria live inside cells where they are protected from foreign DNA by a series of cellular and bacterial membranes. Therefore, more complicated and indirect approaches were applied to mutate Chlamydia genes.

The procedure, called Targeting Induced Local in Genomes (TILLING), has been used for years in plant genetics but is new to bacterial genetics. In their study, NIAID scientists used TILLING to successfully change the function of a specific Chlamydia gene. After creating a library of chemically mutated Chlamydia bacteria, they looked for mutations in a specific target gene. The analysis yielded a mutant with a single in the target gene; that change both inactivated the gene and greatly weakened the ability of the organism to survive in laboratory-grown human .

According to the study authors, TILLING may now be used to reveal the unknown function of hundreds of other Chlamydia genes in an effort to better understand these infections and develop new ways to treat and prevent them.

Chlamydia diseases include both sexually transmitted infections, which can result in pelvic inflammatory disease that can cause infertility in women, and trachoma, which can cause blindness and is common in developing nations. More than 1.2 million infections were reported to the U.S. Centers for Disease Control and Prevention in 2009. The World Health Organization estimates that more than 140 million persons have trachoma in regions of Africa, the Middle East, Central and Southeast Asia and Latin America.

More information: L Kari et al. Generation of targeted Chlamydia trachomatis null mutants. Proceedings of the National Academy of Sciences DOI: 10.1073/PNAS.1102229108 (2011).

Related Stories

Recommended for you

New class of RNA tumor suppressors identified

November 23, 2015

A pair of RNA molecules originally thought to be no more than cellular housekeepers are deleted in over a quarter of common human cancers, according to researchers at the Stanford University School of Medicine. Breast cancer ...

Batten disease may benefit from gene therapy

November 11, 2015

In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses ...

Molecular clocks control mutation rate in human cells

November 9, 2015

Every cell in the human body contains a copy of the human genome. Through the course of a lifetime all cells are thought to acquire mutations in their genomes. Some of the mutational processes generating these mutations do ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.